跳至主要内容
临床试验/ACTRN12611000601932
ACTRN12611000601932终止未知

A prospective comparison of corneal cross linking treatment parameters and outcomes for juvenile onset early keratoconus

Dr James MC Alister0 个研究点目标入组 102 人开始时间: 2011年6月10日最近更新:
适应症

试验速览

阶段
未知
状态
终止
发起方
入组人数
102

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
5 Years 至 17 Years(—)
性别
All

入选标准

  • Early Keratoconus must be evidenced by one or more of the following Pentacam derived topographic abnormalities in the study eye
  • 1. Corneal shape factor indicative of keratoconus on Pentacam assessment
  • Abnormal Enhanced Ectasia Display flags abnormalities based on regression analysis of findings compared to normality indices for
  • (A) Corneal thickness spatial profile (CTSP)
  • (B) Percentage thickness increase (PTI)
  • (C) Deviation parameters (D)
  • 2. Thinnest pachymetry of less than 480microm
  • 3. Kmax of greater than 48 D
  • 4. Posterior corneal elevation of greater than 25 microm on Pentacam analysis
  • and be associated with patient reported history, topographic or refraction data which indicates one of the following changes notes in less than a 12 month period of follow up.
  • 5. Patient reported history of visual loss in study eye during last 1 year.
  • 6. An increase of greater than or equal to 0.75 Diopters (D) in the steepest keratometry value (Kmax on Pentacam).
  • 7. An increase of greater than than or equal to 0.50D in regular astigmatism evaluated by manifest subjective refraction.
  • 8. A myopic shift (decrease in the spherical equivalent) on manifest refraction of 0.50D.
  • 9. Corneal thinning of greater than or equal to 15 microm in less then 12 months on the same pachymeter.
  • 10. Unaided visual acuity in the study eye falling from logmar equivalent recorded level of 1.0
  • Patients with other keratoconus characteristics will not be entered into the trial but offered follow up on a 3-6 monthly basis and if there unaided vision falls be invited to participate at that point.

排除标准

  • Exclusion criteria
  • Eyes will not be eligible to be recruited into the trial if anyone or more of the following apply:
  • 1. Patient age is 18 years or older
  • 2. There is a history of previous corneal surgery.
  • 3. Corneal pachymetry of less than 340microm (thinnest point measured by Pentacam topographer.
  • 4. Insufficient ability to comply with full testing involved in the study
  • 5.The presence of visually significant corneal stromal scarring.
  • 6. The existence of other corneal pathology.
  • 7. A history of herpetic keratitis, chemical injury, or delayed epithelial healing.
  • 8. Recurrent corneal erosion syndrome.
  • 9. Pregnancy or breast-feeding at the time of the initial treatment.
  • 10. Allergy to Riboflavin.

研究者

发起方
Dr James MC Alister

相似试验